CALL/MERCK & CO./150/0.1/20.06.25 | Real-time BOERSE MUENCHEN 02:25:54 2024-06-26 pm EDT | ||
| 0.556 EUR | -1.07% |
|
| Current month | +54.02% | ||
| 1 month | +18.80% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-26 | 0.556 | -1.07% |
| 24-06-25 | 0.562 | +6.04% |
| 24-06-24 | 0.53 | +15.72% |
| 24-06-21 | 0.458 | +1.78% |
| 24-06-20 | 0.45 | +16.28% |
Real-time BOERSE MUENCHEN
Last update June 26, 2024 at 02:25 pm EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | Goldman Sachs |
| WKN | GP7724 |
| ISIN | DE000GP77240 |
| Date issued | 2023-06-27 |
| Strike | 150 $ |
| Maturity | 2025-06-20 (359 Days) |
| Parity | 10 : 1 |
| Emission price | 0.33 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.65 € |
|---|---|
| Lowest since issue | 0.076 € |
| Spread | 0.02 € |
| Spread % | 3.77% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.5
USD
Average target price
142.7
USD
Spread / Average Target
+8.50%
- Stock Market
- Warrants
- Warrant
